Approval · Notice of Compliance 23742 · 2020
COLD + SINUS: Notice of Compliance 23742
Issued June 9, 2020
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 23742
- Date
- June 9, 2020
- Company
- Vita Health Products Inc.Winnipeg, Manitoba, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Labelling Only
- Reason
- Labelling updates to comply with the Plain Language Labelling requirements for private brands
- Canadian reference product
- ADVIL COLD + SINUS (Pfizer Consumer Healthcare, a division of Pfizer Canada ULC)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COLD + SINUS | 02352281 | Marketed |
Medicinal ingredients
- IBUPROFEN 200 MG per TAB
- PSEUDOEPHEDRINE HCL 30 MG per TAB